RecruitingNot ApplicableNCT06855732

Pain Self-Management and Treatment Engagement for Patients Taking Opioids

Pain Self-Management Intervention to Reduce Pain & Improve MOUD Engagement in Primary Care: A Randomized Trial


Sponsor

University of Pittsburgh

Enrollment

204 participants

Start Date

Nov 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participants engage in treatment for opioid use? Researchers will compare PSM to standard care to see if PSM is effective in managing chronic pain and engagement in treatment. Participants will: * Take part in the PSM program or receive standard care for 12 weeks after enrolling in the study * Complete surveys every 3 months for 9 months (total of 4 visits) Participants will receive compensation for participating in the study. There are risks associated with participating in the study, including breach of confidentiality and psychological distress caused by discussing difficult topics.


Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Adults at least 18 years old
  • Ability to speak, read, and understand English
  • Capable of providing informed consent
  • Access to phone and/or internet
  • Current (defined as at least 1 primary care visit in the past 3 years) or new (confirmed appointment) primary care patient at a participating clinic
  • Must meet criteria for OUD or opioid misuse based on at least one of the following:
  • OUD Misuse Screening score of 3 or more (sometimes or more) on at least one of the questions
  • Meets criteria for DSM-5 Opioid Use Disorder on MINI-J
  • Documented diagnosis of Opioid use Disorder (OUD)
  • Have bothersome (Grade 2) or high impact chronic pain (Grade 3), based on the Graded Chronic Pain Scale-Revised (GCPS-R)

Exclusion Criteria7

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Under 18 years of age
  • Have cancer-related pain
  • Are currently in jail, prison, overnight/residential facility as required by court of law or have pending legal action that could prevent participation in study activities
  • Have received prescribed, administered, or dispensed MOUD (buprenorphine, methadone, naltrexone) as maintenance treatment for OUD (excluding acute or short-term (< 7 days) use of these medications to manage opioid withdrawal or pain management) within the past 90 days
  • Had an intentional suicide attempt within the past 3 months
  • The investigators will not exclude individuals with common comorbidities, such as depression, anxiety, or alcohol, methamphetamine, and other substance use disorders.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALUsual Care

Usual care refers to the standard of care that patients receive at their primary care clinic. The standard of care for patients is to discuss chronic pain with their providers at their discretion, and for providers to offer buprenorphine for OUD and/or provide referrals to specialty addiction treatment programs in the local community. Participants will continue to have access to usual care for chronic pain, which could include pain clinic visits, physical therapy, medication (e.g., gabapentin), and/or seeing a counselor, psychiatrist, or psychologist. The study protocol will not interfere with usual clinical care.

BEHAVIORALPain Self-Management

PSM is a manualized behavioral intervention tailored to patients in primary care with opioid misuse/OUD. The PSM intervention that consists of ten sessions/modules. Participants will be offered a total of 10 PSM sessions, delivered weekly over a 12-week intervention period starting from the date of study enrollment. A trained staff interventionist will lead the 60-minute sessions using a participant study manual that outlines the content for all 10 sessions. The first two sessions, "Introduction" and "Navigating Conversations About Opioids", are mandatory. Participants can choose the order of the remaining 8 sessions, prioritizing those they are most interested in. Additional session topics are: Stress Management and Your Pain, Relaxation Techniques to Help Your Pain, Thinking Differently About Your Pain, Sleeping Better to Help Your Pain, Physical Activity and Your Pain, Mood and Your Pain, and Communicating with Others.


Locations(16)

Renaissance Family Practice - Hampton Office

Allison Park, Pennsylvania, United States

Renaissance Family Practice - RIDC Office

Blawnox, Pennsylvania, United States

Renaissance Family Practice - Glenshaw Office

Glenshaw, Pennsylvania, United States

Renaissance Family Practice - Millvale Office

Pittsburgh, Pennsylvania, United States

Community Medicine, Inc.

Pittsburgh, Pennsylvania, United States

UPMC General Internal Medicine-Montefiore

Pittsburgh, Pennsylvania, United States

Renaissance Family Practice - Aspinwall Office

Pittsburgh, Pennsylvania, United States

UPMC General Internal Medicine-Shadyside (Shea Medical Center)

Pittsburgh, Pennsylvania, United States

Renaissance Family Practice - Harmarville Office

Pittsburgh, Pennsylvania, United States

UPMC General Internal Medicine-Turtle Creek

Turtle Creek, Pennsylvania, United States

Renaissance Family Practice - Penn Hills Office

Verona, Pennsylvania, United States

UPMC General Internal Medicine-South

West Mifflin, Pennsylvania, United States

St. Joseph's Rural Health Clinic (WVU Medicine)

Buckhannon, West Virginia, United States

Harpers Ferry Family Medicine (WVU Medicine)

Harpers Ferry, West Virginia, United States

WVU Medicine University Town Centre

Morgantown, West Virginia, United States

WVU Medicine Primary Care

Shepherdstown, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06855732


Related Trials